Coiante Scott M
SEC insider (Form 3/4/5 filer). CIK 0001608536. SVP, Chief Financial Officer at LEXICON PHARMACEUTICALS, INC. (LXRX). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2026. Located in SPRING, TX.
Companies Coiante Scott M has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, SVP, Chief Financial Officer
Coiante Scott M
CIK: 0001608536
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect54.9K shares at avg. $1.47$81K - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect160.2K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
409K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
272.7K shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
721.1K shares- - Feb 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
480.7K shares- - Jan 2, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
230K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 54,881 | $1.47 | $80,675 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 160,237 | - | $0 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 409,020 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 272,680 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 721,070 | - | - | Direct |
| Feb 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 480,710 | - | - | Direct |
| Jan 2, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 230,000 | - | - | Direct |
1-7 of 7 transactions